Boditech Med Inc. is The leader of POCT (Point of Care Testing).
Boditech Med has been established as an antibody developing and manufacturing business in 1998. They’ve changed their business direction to in-vitro diagnostic market in 2000 considering the potential of the market segment. Since then, they have reached current position as a leading company in the POCT market.
Boditech Med has dominated China's POCT market for infection diseases market in the mid 2000’s and providing in-vitro diagnostic solutions over the 120 countries around the world. Also, 100 million of IVD tests have been implemented with its 73,000 IVD analyzers. Boditch Med is constantly striving to become a global in-vitro diagnostic company realizing the value of respect for life.
